ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. Earnings per share

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.7B
P/E ratio
-45.6x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025-6.3-278.19%
Mar 31, 20243.5-119.65%
Mar 31, 2023-18+46.49%
Mar 31, 2022-12.3+6.70%
Mar 31, 2021-11.5+62.52%
Mar 31, 2020-7.1-13.89%
Mar 31, 2019-8.2-246.35%
Mar 31, 20185.6-17.62%
Mar 31, 20176.8-140.56%
Mar 31, 2016-16.8-7.80%
Mar 31, 2015-18.2-19.21%
Mar 31, 2014-22.5-23.52%
Mar 31, 2013-29.5-1.70%
Mar 31, 2012-30

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat